Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Proven Management Teams - One of the Keys to Success in the Life Science Industry

In an article in Pharmexec, May 2024, the author identified seven essential attributes that investors look for before investing in Life Sciences. Among the seven was a “proven management team”. And this was described as “paramount”.

I remembered seeing something similar in Excedr’s online piece on ‘Top VC Firms for Biotech in 2024: Supporting Innovation & Growth’, where they cited “fostering a strong management team” as “the biggest factor that smart investors consider”.

ON Helix 2025: A Snapshot of Disruptive Innovation in Translational Research

by Alicia Gailliez, Business Development Manager, One Nucleus

This year’s ON Helix conference at the Babraham Research Campus brought together biotech innovators, service providers, pharma leaders, investors, and academics in an interactive atmosphere to explore cutting-edge developments in tools, therapeutics, devices, and ecosystems that are shaping the future of translational research.

RESI Boston

RESI Boston 2025, a key component of Biotech Week Boston, will take place on September 17 at the Westin Copley Place, followed by two days of virtual partnering on September 18-19. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. The Westin Copley Place, serving as the RESI venue, is strategically located just a 10-minute walk from the Hynes Convention and Exhibition Center, the main hub for Biotech Week Boston events.

Veranova Appoints Thomas Rohrer as Vice President of Bioconjugation

July 28, 2025
Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Thomas Rohrer as Vice President of Bioconjugation. This appointment follows a recently announced investment to establish cGMP bioconjugation capabilities at its Devens, MA site.

Subscribe to